BioSpace News Archive

The year kicked off with a bang as multiple companies raced to a public listing.

On Monday, Intra-Cellular Therapies announced that the FDA has approved CAPLYTA to treat the deep depressive episodes of patients with bipolar I or II.

Mergers and acquisitions are part of the lifeblood of the pharmaceutical industry, as companies flex their pocketbooks to acquire pipelines and talent to bolster and complement their own programs.

Going through the most newsworthy stories of the year, BioSpace found trends more than one big story, topics that just kept rising again and again. Here’s a look.

Gynecological disease refers to a wide range of medical conditions related to the female reproductive system.

Active pharmaceutical ingredients refer to vital chemicals that are responsible for making the drug work. Depending on type, biotech/biological API, synthetic chemical API, high-potency API, plant extracts API, and classical fermentation API are some of the products available in the active pharmaceutical ingredients market.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global antimicrobial susceptibility test market is expected to expand at a remarkable pace over the forecast period, finds Fact.MR.

The US depth of anesthesia monitoring market has been anticipated to experience innumerable growth opportunities in the upcoming years.

Sensorion, a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent hearing loss disorders, announces the appointment of Scott D. Myers as Chairman of its Board of Directors and Independent Director.

XNK Therapeutics AB (“XNK”) today announced the appointment of Dr. Gunilla Enblad, Professor of oncology at Uppsala University, and Dr. Rizwan Romee, Associate Professor of Medicine at Harvard Medical School, as scientific advisors.